MiMedx Group

About:

MiMedx Group is a wound care and a therapeutic biologics company.

Website: http://mimedx.com

Twitter/X: mimedx

Top Investors: Medical Technology Enterprise Consortium, Hayfin Capital Management, Essex Woodlands Healthcare Partners

Description:

MiMedx Group developing and distributing human placental tissue allografts with patent-protected processes for multiple sectors of healthcare. They processes the human placental tissue utilizing its proprietary purion process methodology, among other processes, to produce allografts by employing aseptic processing techniques in addition to terminal sterilization.

Total Funding Amount:

$266M

Estimated Revenue Range:

$100M to $500M

Headquarters Location:

Marietta, Georgia, United States

Founded Date:

2008-02-28

Contact Email:

careers(AT)mimedx.com

Founders:

Parker H. Petit

Number of Employees:

501-1000

Last Funding Date:

2022-05-31

IPO Status:

Public

Industries:

© 2025 bioDAO.ai